Gumansing, Eleza L.
HRN: 25-54-35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/23/2024
07/29/2024
IV
4.5 Gms
Q8H
Pleural Effusion CAP HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes